S&P 500   3,325.01 (+0.56%)
DOW   27,133.13 (+1.14%)
QQQ   271.25 (+0.32%)
AAPL   437.71 (-0.22%)
MSFT   213.19 (-0.05%)
FB   250.59 (+0.30%)
GOOGL   1,480.19 (+0.47%)
AMZN   3,203.93 (+2.07%)
NVDA   452.72 (+0.80%)
CGC   19.06 (-1.35%)
BABA   265.21 (+1.15%)
TSLA   1,492.04 (+0.34%)
MU   50.98 (-0.62%)
GE   6.23 (+1.47%)
AMD   85.28 (+0.28%)
T   29.81 (-0.67%)
F   7.00 (+2.04%)
ACB   10.65 (-0.75%)
GILD   69.29 (-2.24%)
NFLX   505.80 (-0.75%)
DIS   127.87 (+9.02%)
BAC   25.42 (+1.64%)
BA   172.21 (+4.33%)
S&P 500   3,325.01 (+0.56%)
DOW   27,133.13 (+1.14%)
QQQ   271.25 (+0.32%)
AAPL   437.71 (-0.22%)
MSFT   213.19 (-0.05%)
FB   250.59 (+0.30%)
GOOGL   1,480.19 (+0.47%)
AMZN   3,203.93 (+2.07%)
NVDA   452.72 (+0.80%)
CGC   19.06 (-1.35%)
BABA   265.21 (+1.15%)
TSLA   1,492.04 (+0.34%)
MU   50.98 (-0.62%)
GE   6.23 (+1.47%)
AMD   85.28 (+0.28%)
T   29.81 (-0.67%)
F   7.00 (+2.04%)
ACB   10.65 (-0.75%)
GILD   69.29 (-2.24%)
NFLX   505.80 (-0.75%)
DIS   127.87 (+9.02%)
BAC   25.42 (+1.64%)
BA   172.21 (+4.33%)
S&P 500   3,325.01 (+0.56%)
DOW   27,133.13 (+1.14%)
QQQ   271.25 (+0.32%)
AAPL   437.71 (-0.22%)
MSFT   213.19 (-0.05%)
FB   250.59 (+0.30%)
GOOGL   1,480.19 (+0.47%)
AMZN   3,203.93 (+2.07%)
NVDA   452.72 (+0.80%)
CGC   19.06 (-1.35%)
BABA   265.21 (+1.15%)
TSLA   1,492.04 (+0.34%)
MU   50.98 (-0.62%)
GE   6.23 (+1.47%)
AMD   85.28 (+0.28%)
T   29.81 (-0.67%)
F   7.00 (+2.04%)
ACB   10.65 (-0.75%)
GILD   69.29 (-2.24%)
NFLX   505.80 (-0.75%)
DIS   127.87 (+9.02%)
BAC   25.42 (+1.64%)
BA   172.21 (+4.33%)
S&P 500   3,325.01 (+0.56%)
DOW   27,133.13 (+1.14%)
QQQ   271.25 (+0.32%)
AAPL   437.71 (-0.22%)
MSFT   213.19 (-0.05%)
FB   250.59 (+0.30%)
GOOGL   1,480.19 (+0.47%)
AMZN   3,203.93 (+2.07%)
NVDA   452.72 (+0.80%)
CGC   19.06 (-1.35%)
BABA   265.21 (+1.15%)
TSLA   1,492.04 (+0.34%)
MU   50.98 (-0.62%)
GE   6.23 (+1.47%)
AMD   85.28 (+0.28%)
T   29.81 (-0.67%)
F   7.00 (+2.04%)
ACB   10.65 (-0.75%)
GILD   69.29 (-2.24%)
NFLX   505.80 (-0.75%)
DIS   127.87 (+9.02%)
BAC   25.42 (+1.64%)
BA   172.21 (+4.33%)
Log in

ASX:NHLNovita Healthcare Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.05
MA: A$0.06
A$0.09
52-Week Range N/A
Volume8.20 million shs
Average VolumeN/A
Market Capitalization$39.71 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Novita Healthcare Limited engages in the development and commercialization of healthcare technologies in Australia. The company operates through Research and Development, Healthcare/Workforce Management, and Investments segments. It offers TALI Train, a game-based training program to treat and monitor cognitive problems, such as attention difficulties in early childhood. The company also develops a technology solution for care or support professionals looking for employment, as well as for aged care or disability support providers needing staff. In addition, it primarily invests in Australian equities. The company was formerly known as Avexa Limited and changed its name to Novita Healthcare Limited in December 2016. Novita Healthcare Limited was founded in 2004 and is based in Glen Iris, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone61 3 9192 9937

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$913,867.00
Book ValueA$0.01 per share

Profitability

Miscellaneous

Employees13
Market Cap$39.71 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NHL News and Ratings via Email

Sign-up to receive the latest news and ratings for NHL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Novita Healthcare (ASX:NHL) Frequently Asked Questions

How were Novita Healthcare's earnings last quarter?

Novita Healthcare Ltd (ASX:NHL) issued its earnings results on Tuesday, February, 26th. The company reported $0.00 earnings per share for the quarter.
View Novita Healthcare's earnings history
.

Has Novita Healthcare been receiving favorable news coverage?

Media coverage about NHL stock has been trending somewhat negative this week, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Novita Healthcare earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the near term.
View the latest news about Novita Healthcare
.

Who are some of Novita Healthcare's key competitors?

Who are Novita Healthcare's key executives?

Novita Healthcare's management team includes the following people:
  • Ms. Magda Klapakis, Head of Fin. & Financial Controller
  • Dr. Hannah Kirk, Chief Research Officer
  • Mr. Glenn Smith, COO & MD
  • Mr. Stephen Denaro BCom, GradDipApp CG, CA, MAICD, Company Sec.

What is Novita Healthcare's stock symbol?

Novita Healthcare trades on the ASX under the ticker symbol "NHL."

How big of a company is Novita Healthcare?

Novita Healthcare has a market capitalization of $0.00 and generates $913,867.00 in revenue each year. Novita Healthcare employs 13 workers across the globe.

What is Novita Healthcare's official website?

The official website for Novita Healthcare is www.novitahealthcare.com.au.

How can I contact Novita Healthcare?

The company can be reached via phone at 61 3 9192 9937.

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.